A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment
Arabella Young(The University of Queensland), Mark J. Smyth(The University of Queensland), Deborah S. Barkauskas(QIMR Berghofer Medical Research Institute), Éric Vivier(Centre d’Immunologie de Marseille-Luminy), Joel Linden(La Jolla Institute for Immunology), Yulong Gao(The University of Queensland), Fernando Souza-Fonseca-Guimarães(The University of Queensland), Ann‐Marie Patch(QIMR Berghofer Medical Research Institute), Mariapia A. Degli‐Esposti(The University of Western Australia), Gene Lin(La Jolla Institute for Immunology), Meriem Messaoudene(Centre Hospitalier de l’Université de Montréal), Shin Foong Ngiow(Parker Institute for Cancer Immunotherapy), Jérôme D. Coudert(The University of Western Australia), Laurence Zitvogel(Inserm), Nicola Waddell(QIMR Berghofer Medical Research Institute), Nicholas D. Huntington(The University of Melbourne), Kimberley Stannard(QIMR Berghofer Medical Research Institute)
Cited by 378
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Functions of natural killer cells
|Nature Immunology|2008|3.8k
Immune surveillance of tumors
|Journal of Clinical Investigation|2007|1.4k
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
|Annals of Oncology|2014|1.3k
TLR3 Deficiency in Patients with Herpes Simplex Encephalitis
|Science|2007|1.1k